UMass Chan Medical School is already feeling the cuts in federal funding to its scientific research enterprise.
All hiring and discretionary spending at the school has been paused, and roughly 200 employees have been laid off or furloughed, according to UMass Chan. The school has paused faculty recruitment and significantly reduced the incoming class size at its Morningside Graduate School of Biomedical Sciences. UMass Chan’s research engine is strong on gene therapy and rare disease work.
WATCH ANYTIME FOR FREE Stream NBC10 Boston news for free, 24/7, wherever you are.
More on this story from Boston Business Journal